Modulation of Lipid Metabolism by Deep-Sea Water in Cultured Human Liver (HepG2) Cells

[1]  E. Guallar,et al.  Effect of Supplementation With High-Selenium Yeast on Plasma Lipids , 2011, Annals of Internal Medicine.

[2]  The Effects of Selenium Supplements on Blood Cholesterol Levels , 2011, Annals of Internal Medicine.

[3]  B. Viollet,et al.  AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives , 2009, Acta physiologica.

[4]  J. Yun,et al.  Anti-obesity and Antidiabetic Effects of Deep Sea Water on ob/ob Mice , 2009, Marine Biotechnology.

[5]  J. Yun,et al.  Inhibitory Effect of Deep-sea Water on Differentiation of 3T3-L1 Adipocytes , 2009, Marine Biotechnology.

[6]  J. Park,et al.  Alpha‐lipoic acid decreases hepatic lipogenesis through adenosine monophosphate‐activated protein kinase (AMPK)‐dependent and AMPK‐independent pathways , 2008, Hepatology.

[7]  Takeshi Yasukawa,et al.  Deep-sea water improves cardiovascular hemodynamics in Kurosawa and Kusanagi-Hypercholesterolemic (KHC) rabbits. , 2008, Biological & pharmaceutical bulletin.

[8]  B. Viollet,et al.  Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders , 2006, The Journal of physiology.

[9]  P. Savage,et al.  Magnesium Intake and Incidence of Metabolic Syndrome Among Young Adults , 2006, Circulation.

[10]  R. Heath,et al.  Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. , 2005, Cell metabolism.

[11]  G. Jahreis,et al.  Cholesterol metabolism is affected by calcium phosphate supplementation in humans. , 2005, The Journal of nutrition.

[12]  D. Hardie.  The AMP-activated protein kinase pathway – new players upstream and downstream , 2004, Journal of Cell Science.

[13]  M. Seelig,et al.  Comparison of Mechanism and Functional Effects of Magnesium and Statin Pharmaceuticals , 2004, Journal of the American College of Nutrition.

[14]  J. Breslow,et al.  Intracellular Cholesterol Transport , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Kazutoshi Nakamura,et al.  Effects of desalted deep seawater on hematologic and blood chemical values in mice. , 2004, The Tohoku journal of experimental medicine.

[16]  Jessica D. Ryan,et al.  Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS. , 2004, Analytical biochemistry.

[17]  F. Maehira,et al.  Ameliorative effect of deep-sea water on biochemical and mechanical properties of bone in SAMP6 and SAMR1 , 2004 .

[18]  D. Commenges,et al.  Cardiovascular mortality and calcium and magnesium in drinking water: An ecological study in elderly people , 2002, European Journal of Epidemiology.

[19]  M. Prentki,et al.  Amp kinase and malonyl-coa: Targets for therapy of the metabolic syndrome , 2004, Nature Reviews Drug Discovery.

[20]  M. Miyamura,et al.  Pharmacological activity of deep-sea water: examination of hyperlipemia prevention and medical treatment effect. , 2003, Biological & pharmaceutical bulletin.

[21]  C. Bouchard,et al.  Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. , 2003, The American journal of clinical nutrition.

[22]  R. Evans,et al.  Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.

[23]  R. Evans,et al.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. , 2003, Cell.

[24]  Celeste Eng,et al.  Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. , 2002, The Journal of clinical investigation.

[25]  W. Cefalu,et al.  Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. , 2002, The Journal of nutrition.

[26]  E. Falk,et al.  Oral Magnesium Supplementation Induces Favorable Antiatherogenic Changes in ApoE-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[27]  A. Mufti,et al.  The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. , 2000, Saudi medical journal.

[28]  Y. Ikegami,et al.  Application of Minerals in Deep Seawater , 2000 .

[29]  D. Hardie,et al.  AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.

[30]  M. McQueen,et al.  Reverse cholesterol transport--a review of the process and its clinical implications. , 1997, Clinical biochemistry.

[31]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[32]  P. Macfarlane,et al.  West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .

[33]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[34]  P. Metcalf,et al.  Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. , 1995, Journal of clinical epidemiology.

[35]  M. Brown,et al.  Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[37]  P. Wilson,et al.  Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. , 1994, Journal of lipid research.

[38]  A. Lusis,et al.  Effect of dietary cholesterol and taurocholate on cholesterol 7 alpha-hydroxylase and hepatic LDL receptors in inbred mice. , 1993, Journal of lipid research.

[39]  B. Draznin,et al.  Cytosolic calcium and insulin resistance in elderly patients with essential hypertension. , 1992, American journal of hypertension.

[40]  A. S. Abraham,et al.  The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. , 1992, Metabolism: clinical and experimental.

[41]  Y. Ouchi,et al.  Effect of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits. , 1990, Arteriosclerosis.

[42]  N. Javitt.  Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  H. Brewer,et al.  Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review. , 1987, Metabolism: clinical and experimental.

[44]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[45]  Y. Rayssiguier.  Magnesium, lipids and vascular diseases. Experimental evidence in animal models. , 1986, Magnesium.

[46]  B. Fleshler,et al.  The Liver: Biology and Pathobiology , 1983 .